Comparison of Human Ehrlichiosis Agent Genomes

人类埃利希体病病原体基因组的比较

基本信息

  • 批准号:
    7911775
  • 负责人:
  • 金额:
    $ 36.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-09-03 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ehrlichia chaffeensis infects monocytes and macrophages, and causes a potentially fatal emerging infectious disease called Human monocytic ehrlichiosis (HME). The complete E. chaffeensis Arkansas genome sequence was published in 2006. This is also the only strain for which experimental pathogenesis data are available. Severity of HME varies from asymptomatic infection to death. Our overall hypothesis in the proposed study is that comparative genome sequence analysis combined with comparative pathogenesis studies of multiple E. chaffeensis isolates can provide valuable insights into potential E. chaffeensis virulence determinants and new intervention targets. The specific aims are as follows: 1. Identify polymorphic genes or genomic regions of E. chaffeensis strains by CGH using densely tiled microarray and confirm by DNA sequencing. 2. Determine phenotypes of E. chaffeensis strains in established animal models. 3. Analyze temporal transcriptome profiles of hosts in response to E. chaffeensis strains of distinct virulence, and confirm the results using quantitative RT-PCR, and antibodies specific to selected cytokines and host signaling molecules. 4. Functionally characterize polymorphic E. chaffeensis genes associated with virulence 1) by expressing the virulent and the avirulent versions of recombinant proteins or by transfection of host cells with the candidate virulent gene to study their effects on target host cell functions; 2) by making antibodies to the recombinant proteins and localizing the proteins by confocal immunofluorescent or immunogold electron microscopy: 3) by identifying host interacting proteins by immunoprecipitation of host/bacterial protein complexes and by yeast two-hybrid system: 4) by determining in vitro infection neutralizing effects of the antibodies; and/or by immunizing immunocompetent animals with recombinant proteins or passively immunizing SCID mice with specific antibodies, and challenging them with the virulent strain. The proposed study will identify novel E. chaffeensis virulence determinants and their pathogenic mechanisms. The results may point to potential chemotherapy, chemopreventive and/or vaccine candidates for treatment and prevention of human ehrlichiosis.
描述(申请人提供):查菲埃立克体感染单核细胞和巨噬细胞,并导致一种潜在的致命的新出现的传染病,称为人类单核细胞埃立克体病(HME)。阿肯色州查菲肠杆菌的完整基因组序列于2006年公布。这也是唯一有实验发病机制数据的菌株。HME的严重程度从无症状感染到死亡不等。我们在这项研究中的总体假设是,比较基因组序列分析与多个查菲埃希菌分离株的致病机制比较研究相结合,可以为查菲埃希菌潜在的毒力决定因素和新的干预靶点提供有价值的见解。具体目标如下: 1.利用高密度芯片CGH技术鉴定查菲乳杆菌菌株的多态基因或基因组区域,并经DNA测序证实。 2.在已建立的动物模型中确定查菲埃希菌菌株的表型。 3.分析寄主对不同毒力的查菲埃希氏菌菌株的时间转录组图谱,并使用定量RT-PCR和针对选定的细胞因子和寄主信号分子的抗体来验证结果。 4)通过表达重组蛋白的毒力和无毒版本,或通过将候选毒力基因导入宿主细胞以研究它们对靶宿主细胞功能的影响;2)针对重组蛋白制造抗体,并通过共聚焦免疫荧光或免疫金电子显微镜定位蛋白:3)通过免疫沉淀宿主/细菌蛋白复合体和酵母双杂交系统鉴定与宿主相互作用的蛋白:4)通过确定抗体的体外感染中和作用;和/或通过用重组蛋白免疫具有免疫活性的动物或用特定的抗体被动免疫SCID小鼠,并用毒力株攻击它们。这项拟议的研究将确定新的查菲埃希氏菌毒力决定因素及其致病机制。这一结果可能为治疗和预防人类埃立克体病提供潜在的化疗、化学预防和/或疫苗候选。

项目成果

期刊论文数量(15)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.
  • DOI:
    10.1093/infdis/jis313
  • 发表时间:
    2012-07
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. Rahman;Zhihui Cheng;J. Matsuo;Y. Rikihisa
  • 通讯作者:
    M. Rahman;Zhihui Cheng;J. Matsuo;Y. Rikihisa
Evaluation of sensitivity and specificity of a Mycoplasma haemomuris-specific polymerase chain reaction test.
血鼠支原体特异性聚合酶链反应试验的敏感性和特异性评估。
  • DOI:
  • 发表时间:
    2002
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Zhang,Chunbin;Rikihisa,Yasuko
  • 通讯作者:
    Rikihisa,Yasuko
Analysis of p51, groESL, and the major antigen P51 in various species of Neorickettsia, an obligatory intracellular bacterium that infects trematodes and mammals.
对新立克次体(一种感染吸虫和哺乳动物的必需细胞内细菌)不同物种中的 p51、groESL 和主要抗原 P51 进行分析。
  • DOI:
    10.1128/jcm.42.8.3823-3826.2004
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    9.4
  • 作者:
    Rikihisa,Yasuko;Zhang,Chunbin;Kanter,Manuel;Cheng,Zhihui;Ohashi,Norio;Fukuda,Takeo
  • 通讯作者:
    Fukuda,Takeo
Comparative genomics of emerging human ehrlichiosis agents.
  • DOI:
    10.1371/journal.pgen.0020021
  • 发表时间:
    2006-02
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Dunning Hotopp JC;Lin M;Madupu R;Crabtree J;Angiuoli SV;Eisen JA;Seshadri R;Ren Q;Wu M;Utterback TR;Smith S;Lewis M;Khouri H;Zhang C;Niu H;Lin Q;Ohashi N;Zhi N;Nelson W;Brinkac LM;Dodson RJ;Rosovitz MJ;Sundaram J;Daugherty SC;Davidsen T;Durkin AS;Gwinn M;Haft DH;Selengut JD;Sullivan SA;Zafar N;Zhou L;Benahmed F;Forberger H;Halpin R;Mulligan S;Robinson J;White O;Rikihisa Y;Tettelin H
  • 通讯作者:
    Tettelin H
Molecular characterization of Aegyptianella pullorum (Rickettsiales, Anaplasmataceae).
鸡白伊蚊(立克次体目,无形体科)的分子特征。
  • DOI:
    10.1128/jcm.41.11.5294-5297.2003
  • 发表时间:
    2003
  • 期刊:
  • 影响因子:
    9.4
  • 作者:
    Rikihisa,Yasuko;Zhang,Chunbin;Christensen,BruceM
  • 通讯作者:
    Christensen,BruceM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YASUKO RIKIHISA其他文献

YASUKO RIKIHISA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YASUKO RIKIHISA', 18)}}的其他基金

Targeted Prevention of Human Ehrlichiosis
人类埃利希体病的针对性预防
  • 批准号:
    10755407
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Targeted Prevention of Human Ehrlichiosis
人类埃利希体病的针对性预防
  • 批准号:
    10470709
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Targeted Prevention of Human Ehrlichiosis
人类埃利希体病的针对性预防
  • 批准号:
    10667509
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Targeted Prevention of Human Ehrlichiosis
人类埃利希体病的针对性预防
  • 批准号:
    9990077
  • 财政年份:
    2021
  • 资助金额:
    $ 36.42万
  • 项目类别:
Keys to prevent iron hijacking and infection by intracellular bacteria
防止铁劫持和细胞内细菌感染的关键
  • 批准号:
    10552677
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Keys to prevent iron hijacking and infection by intracellular bacteria
防止铁劫持和细胞内细菌感染的关键
  • 批准号:
    10330564
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Keys to prevent iron hijacking and infection by intracellular bacteria
防止铁劫持和细胞内细菌感染的关键
  • 批准号:
    10089410
  • 财政年份:
    2020
  • 资助金额:
    $ 36.42万
  • 项目类别:
Inhibition of Ehrlichial Infection by Intracellular Nanobody
细胞内纳米抗体抑制埃利希体感染
  • 批准号:
    9808090
  • 财政年份:
    2019
  • 资助金额:
    $ 36.42万
  • 项目类别:
Keys to prevent cholesterol robbery and infection by intracellular bacteria
防止胆固醇抢劫和细胞内细菌感染的关键
  • 批准号:
    8415504
  • 财政年份:
    2012
  • 资助金额:
    $ 36.42万
  • 项目类别:
Keys to prevent cholesterol robbery and infection by intracellular bacteria
防止胆固醇抢劫和细胞内细菌感染的关键
  • 批准号:
    8270716
  • 财政年份:
    2012
  • 资助金额:
    $ 36.42万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 36.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了